Issues: Vax Specific

Anthrax

Hepatitis B

Hib

Influenza

HPV

Lyme Disease
Meningococcal

MMR    

Pneumococcal

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation

New Vax Status

Thimerosal

Independent Vax  Safety Board

 

Vaccine Info

2014 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links
 

Search
 

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy
 

 

Institute for Vaccine Safety

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street

Room W5041

Baltimore, MD 21205

www.vaccinesafety.edu

 

 

 

 

Components of
DT Vaccines

Excipients Table
Allergens Table
Components Table

 
Indication

To prevent infection with Corynebacterium diphtheriae and Clostridium tetani

Proprietary Name

DT (generic)

Manufacturer

sanofi pasteur

Viability

Inactivated

Microorganism

Corynebacterium diphtheriae and Clostricium tetani

Ages

up to 7 years

Dosage

0.5 mL

Route

Intramuscular

Dose form

Suspension

Appearance

Turbid liquid, white, slightly gray

Concentration (per 0.5 mL)

Diphtheria, 6.7 Lf U
Tetanus, 5 LF U

Preservatives

Thimerosal, ≤ 0.3 mcg

Adjuvant

Aluminum potassium sulfate (≤ 0.25 mg aluminum)

Excipients

Formaldehyde (residual-free), ≤0.02%
Variously formulated with glycine, sodium phosphate, sodium acetate, hydrochloric acid or sodium hydroxide

Allergens

None

Media

Modified Mueller and Miller Pepton-based medium containing bovine extract

Packaging

Single-dose (0.5 mL) vials

Routine Storage

2 to 8 C (36-46 F)
Do Not Freeze

Package Insert Date

Dec 2005

table updated Oct 2013

This page was last updated on February 12, 2014

2014 Institute for Vaccine Safety